1. Home
  2. Browse
  3. Interactions
  4. Infectious Diseases

Infectious Diseases

196 - 210 of 246 Results
Sort Results:
Article: two new protease inhibitors for hepatitis C, Incivek (telaprevir) and Victrelis (boceprevir) August 2011
Article: new ORAL anticoagulant called Xarelto (zuh-REL-toe) August 2011
Commentary: New Drug: Daliresp (Roflumilast) July 2011
Commentary: New Drug: Viibryd (Vilazodone) July 2011
Guideline: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2010) July 2011
Article: stronger dosing limits for simvastatin July 2011
Article: Daliresp (DA-li-resp), a new oral tablet for severe COPD in patients with chronic bronchitis July 2011
Article: two new protease inhibitors for hepatitis C, Victrelis (vic-TREL-is) and Incivek (in-SEE-veck) July 2011
Article: Viibryd (VI-brid) marketed as a new "dual-acting" serotonergic antidepressant July 2011
Chart: Drug Therapy for Methicillin-Resistant Staph Aureus (MRSA) March 2011
Article: methicillin-resistant Staph aureus (MRSA) infections in hospitalized patients March 2011
Article: whether it's safe to combine a calcium channel blocker with a macrolide antibiotic March 2011
Chart: Drug Regimens for Latent Tuberculosis (TB) February 2011
Article: Gilenya (jill-LEN-nee-ya, fingolimod) is the first ORAL drug to reduce relapses in relapsing multiple sclerosis (MS) November 2010
Article: more about trimethoprim/sulfamethoxazole (Bactrim, etc) contributing to increased potassium September 2010